Kilitch Drugs (India) Limited Price (KILITCH.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

15,923,010

(2.1876)%

Kilitch Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, via... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $300-404.95
  • Market Cap 5.06B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Mr. Mukund Prataprai Mehta B.Com., LL.B.
  • IPO Date: September, 29, 2010
  • Country: IN
  • Currency: INR
  • Headquaters: No Data
  • Employees: 168

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation